Pharmaceuticals

Prescription drugs and vaccines have revolutionized healthcare, but how do researchers and industry decide what diseases to pursue?

Ozempic and similar drugs are ushering in a new era of weight management and obesity treatments, and researchers are racing to understand their impact

A loophole in FDA processes means older drugs such as those in oral decongestants weren’t properly tested. Here’s how we learned the most popular one doesn’t work

A deep-learning algorithm helped identify new compounds that are effective against antibiotic-resistant infections in mice, opening the door to AI-guided drug discovery

The active ingredient in Wegovy and Ozempic reduced the risk of heart attacks and strokes in a large trial of people with cardiovascular disease who were considered overweight or had obesity, but the cost and side effects remain barriers

Recent studies evaluate risks associated with drugs such as Wegovy and Mounjaro

Insurance plans could cover blockbuster weight-loss medications such as Wegovy and Ozempic, but the benefits may not be accessible to everyone

A simplified penicillin allergy test could help reduce false positives, but doctors face challenges in using it

The popular decongestant phenylephrine is not effective, an FDA panel found. Here’s what to use instead.

The recent national shortage in chemotherapy drugs points to a need to overhaul the generics market

The new social media trend “budget Ozempic” promotes laxatives and stool softeners for weight loss, but these drugs are dangerous if misused

Ten medications, costing tens of billions of dollars, will be the first to be subject to Medicare price negotiations